Given the association of C2 fibroblasts with pro-inflammatory signaling, interventions aimed at inhibiting C2-related pathways, such as CXCL and VEGF signaling, may help modulate the inflammatory milieu in SLE. This evidence concerns the gene VEGFA and systemic lupus erythematosus.